ClinicalTrials.gov record
Completed Phase 3 Interventional

A Study of Zidovudine in HIV-Infected Patients Who Have Hemophilia

ClinicalTrials.gov ID: NCT00001104

Public ClinicalTrials.gov record NCT00001104. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced May 20, 2026, 2:50 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Placebo Controlled Trial To Evaluate Zidovudine (ZDV) in the Treatment of Human Immunodeficiency Virus (HIV) Infection in Hemophilic Patients

Study identification

NCT ID
NCT00001104
Recruitment status
Completed
Study type
Interventional
Phase
Phase 3
Lead sponsor
National Institute of Allergy and Infectious Diseases (NIAID)
NIH
Enrollment
538 participants

Conditions and interventions

Conditions

Interventions

  • Zidovudine Drug

Drug

Eligibility (public fields only)

Age range
12 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Not listed
Primary completion
Not listed
Completion
Jan 31, 1990
Last update posted
Oct 31, 2021

Ends 1990

United States locations

U.S. sites
23
U.S. states
12
U.S. cities
19
Facility City State ZIP Site status
Los Angeles County - USC Med Ctr Los Angeles California 90033
Univ of California / San Diego Treatment Ctr San Diego California 921036325
Stanford Univ School of Medicine Stanford California 94305
Northwestern Univ Med School Chicago Illinois 60611
Cook County Hosp Chicago Illinois 60612
Chicago Children's Memorial Hosp Chicago Illinois 606143394
Indiana Univ Hosp Indianapolis Indiana 462025250
Tulane Univ School of Medicine New Orleans Louisiana 70112
Children's Hosp of Boston Boston Massachusetts 021155724
Univ of Massachusetts Med Ctr Worcester Massachusetts 01655
Univ of Minnesota Minneapolis Minnesota 55455
Cornell Univ Med Ctr New York New York 10021
Mount Sinai Med Ctr New York New York 10029
Univ of Rochester Medical Center Rochester New York 14642
Univ of North Carolina Chapel Hill North Carolina 275997215
Holmes Hosp / Univ of Cincinnati Med Ctr Cincinnati Ohio 452670405
Univ Hosp of Cleveland / Case Western Reserve Univ Cleveland Ohio 44106
Ohio State Univ Hosp Clinic Columbus Ohio 432101228
Milton S Hershey Med Ctr Hershey Pennsylvania 170330850
Hemophilia Ctr of Western PA / Univ of Pittsburgh Pittsburgh Pennsylvania 15219
Univ of Pittsburgh Med School Pittsburgh Pennsylvania
Baylor College of Medicine Houston Texas 77030
Univ of Washington Seattle Washington 98105

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT00001104, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Oct 31, 2021 · Synced May 20, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT00001104 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →